|
Lymphoid Neoplasia
Citations 51-60 of 299 total displayed.
|
Past content
(since Jan 2009):
|
miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia
- Christian Philipp Pallasch, Michaela Patz, Yoon Jung Park, Susanne Hagist, Daniela Eggle, Rainer Claus, Svenja Debey-Pascher, Alexandra Schulz, Lukas P. Frenzel, Julia Claasen, Nadine Kutsch, Günter Krause, Christine Mayr, Andreas Rosenwald, Christoph Plass, Joachim L. Schultze, Michael Hallek, and Clemens-Martin Wendtner
Blood 2009; 114: 3255-3264.
[Abstract]
[Full text]
[PDF]
Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer–cell lymphoma/leukemia
- Yasuo Yamanaka, Hiroyuki Tagawa, Naoto Takahashi, Atsushi Watanabe, Yong-Mei Guo, Keiko Iwamoto, Junsuke Yamashita, Hirobumi Saitoh, Yoshihiro Kameoka, Norio Shimizu, Ryo Ichinohasama, and Ken-ichi Sawada
Blood 2009; 114: 3265-3275.
[Abstract]
[Full text]
[PDF]
Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance
- Simona Blotta, Pierfrancesco Tassone, Rao H. Prabhala, Piersandro Tagliaferri, David Cervi, Samir Amin, Jana Jakubikova, Yu-Tzu Tai, Klaus Podar, Constantine S. Mitsiades, Alessandro Zullo, Brunella Franco, Kenneth C. Anderson, and Nikhil C. Munshi
Blood 2009; 114: 3276-3284.
[Abstract]
[Full text]
[PDF]
Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2
- Mamta Gupta, Stephen M. Ansell, Anne J. Novak, Shaji Kumar, Scott H. Kaufmann, and Thomas E. Witzig
Blood 2009; 114: 2926-2935.
[Abstract]
[Full text]
[PDF]
Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells
- Ryan A. Wilcox, David A. Wada, Steven C. Ziesmer, Sherine F. Elsawa, Nneka I. Comfere, Allan B. Dietz, Anne J. Novak, Thomas E. Witzig, Andrew L. Feldman, Mark R. Pittelkow, and Stephen M. Ansell
Blood 2009; 114: 2936-2944.
[Abstract]
[Full text]
[PDF]
Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma
- Alfons Navarro, Tania Diaz, Antonio Martinez, Anna Gaya, Aina Pons, Bernat Gel, Carles Codony, Gerardo Ferrer, Carmen Martinez, Emili Montserrat, and Mariano Monzo
Blood 2009; 114: 2945-2951.
[Abstract]
[Full text]
[PDF]
Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility
- Ke Zhang, Daniel Kagan, Wendy DuBois, Richard Robinson, Valery Bliskovsky, William C. Vass, Shuling Zhang, and Beverly A. Mock
Blood 2009; 114: 2952-2960.
[Abstract]
[Full text]
[PDF]
Inhibition of the SDF-1 –CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice
- Akira Kawaguchi, Yasuko Orba, Takashi Kimura, Hidekatsu Iha, Masao Ogata, Takahiro Tsuji, Akira Ainai, Tetsutaro Sata, Takashi Okamoto, William W. Hall, Hirofumi Sawa, and Hideki Hasegawa
Blood 2009; 114: 2961-2968.
[Abstract]
[Full text]
[PDF]
Molecular profiling of CD3–CD4+ T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways
- Marie Ravoet, Catherine Sibille, Chunyan Gu, Myriam Libin, Benjamin Haibe-Kains, Christos Sotiriou, Michel Goldman, Florence Roufosse, and Karen Willard-Gallo
Blood 2009; 114: 2969-2983.
[Abstract]
[Full text]
[PDF]
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial
- Thorsten Zenz, Sonja Häbe, Tina Denzel, Julia Mohr, Dirk Winkler, Andreas Bühler, Antonio Sarno, Silja Groner, Daniel Mertens, Raymonde Busch, Michael Hallek, Hartmut Döhner, and Stephan Stilgenbauer
Blood 2009; 114: 2589-2597.
[Abstract]
[Full text]
[PDF]
|
|
